Concepedia

H. Spiridonidis

HS

Statistics

Publications

3

Citations

2.6K

H-Index

3

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

H. Spiridonidis is an author at The University of Texas MD Anderson Cancer Center specializing in lung cancer, cancer therapeutics, and radiation oncology.

Top concepts

Publications per year

2003–2017

3

Publications

3

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst et al. · JAMA · 2003 · 2.5K citations

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non-Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst et al. · 2017 · 97 citations

, , +14

Efficacy and safety of gefitinib (Iressa, ZD1839), an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with advanced non-small cell lung cancer

MG Kris, Natale Rb, R. Herbst et al. · 2003 · 13 citations

, , +5

1–3 of 3